Trial NCT02115048

View at ClinicalTrials.gov 
Org. Study IDs: TRIO 020

Last trial update was posted on 2019-12-26

MeSH Interventions

Afatinib Letrozole

MeSH Conditions

Breast Neoplasms

Other Conditions


Stopping Reasons

Study was completed as per amended protocol. Protocol was amended to close enrollment earlier than initially planned (study continued as per plan).

Limitations And Caveats

Enrolment was closed prematurely with only 44 participants enrolled compared to what was initially planned (150 participants). Thus, preventing appropriate statistical evaluation (primary/secondary objectives no longer applicable as per protocol).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID